Aldeyra Therapeutics, Inc.Aldeyra Therapeutics, Inc.Aldeyra Therapeutics, Inc.

Aldeyra Therapeutics, Inc.

No trades
See on Supercharts
Market capitalization
‪250.31 M‬USD
−0.64USD
‪−37.54 M‬USD
‪56.55 M‬
Beta (1Y)
5.09

About Aldeyra Therapeutics, Inc.

CEO
Todd C. Brady
Headquarters
Lexington
Employees (FY)
10
Founded
2004
ISIN
US01438T1060
FIGI
BBG0029H8ZF6
Aldeyra Therapeutics, Inc. is a biotechnology company, which engages in research and development activities with related general business planning, including raising capital. It engages in the discovery of therapies designed to treat immune-mediated diseases. The company was founded by Thomas A. Jordan and John E. Dowling on August 13, 2004 and is headquartered in Lexington, MA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ALDX is 4.25 USD — it has decreased by 3.41% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Aldeyra Therapeutics, Inc. stocks are traded under the ticker ALDX.
Aldeyra Therapeutics, Inc. is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Aldeyra Therapeutics, Inc. has a max estimate of 11.00 USD and a min estimate of 7.00 USD.
ALDX earnings for the last quarter are −0.14 USD whereas the estimation was −0.20 USD which accounts for 28.49% surprise. Estimated earnings for the next quarter are −0.11 USD. See more details about Aldeyra Therapeutics, Inc. earnings.
Aldeyra Therapeutics, Inc. revenue for the last quarter amounts to 0 USD despite the estimated figure of 0 USD. In the next quarter revenue is expected to reach ‪3.00 M‬ USD.
Yes, you can track Aldeyra Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, ALDX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Aldeyra Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
ALDX reached its all-time high on Sep 26, 2018 with the price of 16.70 USD, and its all-time low was 1.42 USD and was reached on Oct 16, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 15, 2024, the company has 10.00 employees. See our rating of the largest employees — is Aldeyra Therapeutics, Inc. on this list?